In This Section

Government Relations

ACNM Government Relations Areas of Focus

  • Representation of nuclear physician's interests before Congress and federal regulatory bodies
  • Monthly government affairs reports
  • Electronic issue alerts
  • FDA activities with respect to review and approval of radiopharmaceuticals
  • NRC quality assurance activities
  • Efforts to influence federal funding for nuclear medicine research
  • Educational and training requirements for NRC licensure
  • Nuclear medicine political action committee

Breaking News

ACNM relays concern about Executive Order 13769, suspending the entry of alien nationals from seven countries, to the US President.  Read ACNM's letter to the president.

ACNM responds to the US Nuclear Regulatory Commission Draft Program-Specific Guidance About Medical Use Licenses (NRC-2016-0122), questioning the utility of the proposed revision.  Read ACNM's response.

Latest News

  • July 19, 2018SNMMI Supports Bill Funding Mo-99 Domestic Production
    In a letter to the Senate and House subcommittees on Energy and Water Development, SNMMI President Satoshi Minoshima, MD, PhD, joined with leaders of other medical societies, patient groups, radiopharmaceutical manufacturers and distributors, and medical imaging companies to urge support of a provision in both the Senate and House bills that would provide $20 million in additional funding to continue establishing domestic production of Mo-99.
  • July 13, 2018CMS Proposes 2019 Payment Rule for Physicians
    CMS issued its CY 2019 proposed payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule.
  • July 12, 2018Availability of Mo-99
    Nuclear reactors in both South Africa and Australia are off-line for unscheduled reasons. Efforts are being made to reduce the impact on patients.
  • July 10, 2018SNMMI-ACNM-ASTRO Submit Joint Comments to NRC on Training and Experience Requirements
    SNMMI together with representatives from ACNM and ASTRO offered recommendations for potential updates to the Nuclear Regulatory Commission’s requirements for those who wish to be authorized users of unsealed byproduct material.
  • July 3, 2018SNMMI Opposes Florida Proposal
    SNMMI responds to an attempt to withdraw Medicare coverage of DAT-SPECT with Iodine I-123 Ioflupane (DatScan).
  • View All Government Relations News »